Role of Monoclonal Antibodies in the Treatment of Asthma
BACKGROUND: Patients with severe refractory asthma represent a small subset of the asthmatic population (between 5% and 10% of all patients) but are the greatest burden to the health care system. New treatment approaches developed to manage some of the phenotypes of severe refractory asthma have inc...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley
2013-01-01
|
| Serie: | Canadian Respiratory Journal |
| Accesso online: | http://dx.doi.org/10.1155/2013/183948 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|